Takeaways from COVID-19 Vaccine Hearing with Drug Manufacturers
Washington, D.C. – This week, members of the Energy and Commerce Committee heard directly from representatives of five companies developing a COVID-19 vaccine at an Oversight and Investigations Subcommittee hearing. The drug manufacturers represented were AstraZeneca, Johnson & Johnson, Merck, Moderna, and Pfizer.
These were the witnesses:
Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca
Macaya Douoguih, Head of Clinical Development and Medical Affairs, Janssen Vaccines, Johnson & Johnson
Julie Gerberding, Executive Vice President and Chief Patient Officer, Merck
Stephen Hoge, President, Moderna
John Young, Chief Business Officer, Pfizer